Crossmark

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience

Crossref DOI link: https://doi.org/10.1186/s13014-019-1305-1

Published Online: 2019-06-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhong, Liangzhi

Chen, Lu

Lv, Shengqing

Li, Qingrui

Chen, Guangpeng

Luo, Wen

Zhou, Pu

Li, Guanghui http://orcid.org/0000-0002-7029-0627
License Information

Text and Data Mining valid from 2019-06-13

Version of Record valid from 2019-06-13
More Information

Article History

Received: 26 February 2019

Accepted: 24 May 2019

First Online: 13 June 2019

Ethics approval and consent to participate

: This study was approved by the institutional review board and ethics committee of Xinqiao Hospital, Army Medical University, Chongqing, China.

: Not applicable.

: We declare that we do not have any commercial or associative interests that represent a conflict of interest in connection with the work submitted.

Document is current

Any future updates will be listed below